Studies show overall risks are low, but monitoring helps catch issues early
Glucose Regulation and Insulin Research Researchers apply Tirzepatide in glucose homeostasis studies extensively
This Phase 3 trial showed tirzepatide, a GIP/GLP-1 dual receptor agonist, met the primary objective of non-inferiority versus dulaglutide, a GLP-1 receptor agonist, with an 8% lower rate of major adverse cardiovascular events (MACE) that included cardiovascular death, heart attack or stroke, while delivering greater reductions in A1C and weight
Differentiating Drug-Induced Hot Flashes from Other Causes Not all hot flashes are caused by Semaglutide
The total number of neurons, N(neu), in the inferior olive was estimated using the optical fractionator 32,33,34 : where ssf, asf and hsf are referred to as the section sampling fraction (1/4)